Diabetes/ Diabetes/ Healthcare/ News/ News/ Patients J&J seals $2.1bn deal on sale of major diabetes devices firm Joy Persaud blood glucose monitor, Diabetes, Glucose, J&J, Johnson and Johnson, Platinum Equity 0 Comment As part of its ongoing divestment program, a deal worth $2.1 billion has been struck between Johnson & Share X J&J seals $2.1bn deal on sale of major diabetes devices firm https://pharmaphorum.com/news/jj-deal-glucose-monitoring-system/